Preoperative silent myocardial ischemia. Has it prognostic significance?

A Jánosi1, J Hankóczy, A Vértes

  • 1János Municipal Hospital III, Internal Department and Cardiology, Budapest, Hungary.

Cardiology
|January 1, 1991
PubMed

Insights

Preoperative silent myocardial ischemia, detected by Holter monitoring, predicts a higher risk of perioperative myocardial infarction in patients undergoing coronary artery bypass grafting (CABG). This finding aids in identifying high-risk surgical candidates.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery

Background:

  • Coronary artery bypass grafting (CABG) is a common procedure for managing coronary artery disease.
  • Perioperative myocardial infarction (MI) is a significant complication following CABG, impacting patient outcomes.
  • Identifying preoperative risk factors for perioperative MI is crucial for improving surgical safety.

Purpose of the Study:

  • To investigate the prognostic significance of preoperative silent myocardial ischemia in patients scheduled for CABG.
  • To determine if Holter monitoring can identify patients at increased risk for perioperative MI.

Main Methods:

  • Ninety-five patients with stable-effort angina pectoris undergoing CABG were monitored using Holter for approximately 28 hours before surgery.
  • Electrocardiographic recordings (CM5 and modified inferior lead) were analyzed for silent ST depression.
  • Incidence of perioperative MI was compared between patients with and without silent ischemia.

Main Results:

  • Silent ST depression, indicative of silent ischemia, was detected in 12.6% of patients.
  • Perioperative MI occurred in 12.6% of the total cohort.
  • Patients with preoperative silent ischemia had a significantly higher incidence of perioperative MI (33.3% vs. 9.6%, p=0.034).

Conclusions:

  • Holter monitoring effectively identifies preoperative silent myocardial ischemia.
  • Preoperative silent ischemia is a significant predictor of perioperative myocardial infarction in CABG patients.
  • Further research into preventive strategies for this high-risk group is warranted.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...